ARQT icon

Arcutis Biotherapeutics

185 hedge funds and large institutions have $1.18B invested in Arcutis Biotherapeutics in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 59 increasing their positions, 55 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

0.57% more ownership

Funds ownership: 108.71%109.28% (+0.57%)

5% less capital invested

Capital invested by funds: $1.24B → $1.18B (-$61.9M)

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
185
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.03M
Puts
$2.73M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$9.59M
27
$9.37M
28
$8.98M
29
$8.72M
30
$7.92M
31
$7.79M
32
$7.51M
33
$7.09M
34
$6.99M
35
$6.84M
36
$6.21M
37
$5.9M
38
$5.33M
39
$5.27M
40
$5.24M
41
$4.77M
42
$4.55M
43
$4.54M
44
$4.07M
45
$3.63M
46
$3.35M
47
$3.26M
48
$3.22M
49
$2.97M
50
$2.88M